Lucid Diagnostics Stock Forecast - Simple Regression
| LUCD Stock | USD 0.79 0.02 2.47% |
The Simple Regression forecasted value of Lucid Diagnostics on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.48. Lucid Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Lucid Diagnostics stock prices and determine the direction of Lucid Diagnostics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Lucid Diagnostics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Lucid Diagnostics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Lucid Diagnostics' systematic risk associated with finding meaningful patterns of Lucid Diagnostics fundamentals over time.
Check out Historical Fundamental Analysis of Lucid Diagnostics to cross-verify your projections. Lucid |
Most investors in Lucid Diagnostics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Lucid Diagnostics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Lucid Diagnostics' price structures and extracts relationships that further increase the generated results' accuracy.
Simple Regression model is a single variable regression model that attempts to put a straight line through Lucid Diagnostics price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X. Lucid Diagnostics Simple Regression Price Forecast For the 8th of June
Given 90 days horizon, the Simple Regression forecasted value of Lucid Diagnostics on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.09, mean absolute percentage error of 0.01, and the sum of the absolute errors of 5.48.Please note that although there have been many attempts to predict Lucid Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Lucid Diagnostics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Lucid Diagnostics Stock Forecast Pattern
| Backtest Lucid Diagnostics | Lucid Diagnostics Price Prediction | Buy or Sell Advice |
Lucid Diagnostics Forecasted Value
In the context of forecasting Lucid Diagnostics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Lucid Diagnostics' downside and upside margins for the forecasting period are 0.01 and 6.03, respectively. We have considered Lucid Diagnostics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Lucid Diagnostics stock data series using in forecasting. Note that when a statistical model is used to represent Lucid Diagnostics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.4946 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0884 |
| MAPE | Mean absolute percentage error | 0.1006 |
| SAE | Sum of the absolute errors | 5.48 |
Predictive Modules for Lucid Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lucid Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lucid Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Lucid Diagnostics
For every potential investor in Lucid, whether a beginner or expert, Lucid Diagnostics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lucid Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lucid. Basic forecasting techniques help filter out the noise by identifying Lucid Diagnostics' price trends.Lucid Diagnostics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lucid Diagnostics stock to make a market-neutral strategy. Peer analysis of Lucid Diagnostics could also be used in its relative valuation, which is a method of valuing Lucid Diagnostics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Lucid Diagnostics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Lucid Diagnostics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Lucid Diagnostics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Lucid Diagnostics Market Strength Events
Market strength indicators help investors to evaluate how Lucid Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lucid Diagnostics shares will generate the highest return on investment. By undertsting and applying Lucid Diagnostics stock market strength indicators, traders can identify Lucid Diagnostics entry and exit signals to maximize returns.
| Accumulation Distribution | 28186.31 | |||
| Daily Balance Of Power | (0.25) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 0.79 | |||
| Day Typical Price | 0.79 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) |
Lucid Diagnostics Risk Indicators
The analysis of Lucid Diagnostics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lucid Diagnostics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lucid stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.17 | |||
| Standard Deviation | 5.1 | |||
| Variance | 25.96 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Lucid Stock
When determining whether Lucid Diagnostics is a strong investment it is important to analyze Lucid Diagnostics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lucid Diagnostics' future performance. For an informed investment choice regarding Lucid Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Lucid Diagnostics to cross-verify your projections. For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lucid Diagnostics. If investors know Lucid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lucid Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.26) | Revenue Per Share 0.07 | Quarterly Revenue Growth 1.244 | Return On Assets (0.69) | Return On Equity (2.56) |
The market value of Lucid Diagnostics is measured differently than its book value, which is the value of Lucid that is recorded on the company's balance sheet. Investors also form their own opinion of Lucid Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Lucid Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lucid Diagnostics' market value can be influenced by many factors that don't directly affect Lucid Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lucid Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lucid Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lucid Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.